Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

CINQAIR reslizumab 100 mg/10 mL concentrated solution for intravenous infusion vial (277278)

ARTG ID

277278

ARTG Name

CINQAIR reslizumab 100 mg/10 mL concentrated solution for intravenous infusion vial

Sponsor

Teva Pharma Australia Pty Ltd

ARTG Date

July 25, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Teva Pharma Australia Pty Ltd

Sponsor Item Name

TEVA PHARMA AUSTRALIA PTY LTD

Active Ingredients

Ingredient Name

reslizumab

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy